Impact of opportunistic disease on survival in patients with HIV infection
AIDSPublished 1 January 1998
Richard E. Chaisson, Joel E. Gallant, Jeanne Keruly, Richard D. Moore
Citations187
SJR quartileQ1
SJR score1.21
SNIP0.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Most opportunistic diseases increase the risk of death independently of CD4 cell count, and data support the hypothesis that opportunistic Diseases enhance HIV pathogenesis and further underscore the importance of prophylaxis.
Abstract
Most opportunistic diseases increase the risk of death independently of CD4 cell count. These data support the hypothesis that opportunistic diseases enhance HIV pathogenesis and further underscore the importance of prophylaxis.
Keywords
Immunology and MicrobiologyMedicine
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
BiometrikaLongitudinal data analysis using generalized linear models
18,123 Citations1986Kung‐Yee Liang, Scott L. Zeger
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
7,727 Citations1958Edward L. Kaplan, Paul Meier
ScienceHIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
3,550 Citations1996Alan S. Perelson, Avidan U. Neumann +3 more
A new mathematical model was used to analyze a detailed set of human immunodeficiency virus-type 1 (HIV-1) viral load data collected from five infected individuals after the administration of a potent inhibitor of HIV-1 protease, providing not only a kinetic picture ofAIDS pathogenesis, but also theoretical principles to guide the development of treatment strategies.
SciencePrognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
2,705 Citations1996John W. Mellors, Charles R. Rinaldo +4 more
Plasma viral load was a better predictor of progression to AIDS and death than was the number of CD4+ T cells, and the risk of acquired immunodeficiency syndrome (AIDS) and death in study subjects was directly related to plasma viral load at study entry.
Annals of Internal MedicinePlasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
2,085 Citations1997John W. Mellors, Alvaro Munoz +10 more
This study compared the prognostic value of plasma viral load with that of clinical, serologic, and cellular markers in a large cohort of HIV-infected men and incorporated the two most predictive markers-plasma viral load and CD4+ lymphocyte count-into a regression tree that is useful for assessing the prognosis of individual patients.
Annals of Internal MedicineQuantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion
940 Citations1995John W. Mellors, Lawrence A. Kingsley +5 more
The objective was to compare plasma HIV-1 RNA with determinations of serum p24 antigen, neopterin, and 2-microglobulin levels and CD4+ T-cell counts as predictors of outcome in a cohort of homosexual men with documented HIV- 1 seroconversion.
New England Journal of MedicineChanges in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
734 Citations1996William A. O’Brien, Pamela Hartigan +7 more
Treatment-induced changes in the plasma HIV-1 RNA level and the CD4+ lymphocyte count are valid predictors of the clinical progression of HIV-related disease and can be used to assess the efficacy of zidovudine and possibly other antiretroviral drugs as well.
The Journal of ImmunologyEffect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
497 Citations1996Delia Goletti, Drew Weissman +8 more
Whether MTB modulates HIV infection in vivo and in an in vitro model is determined and this MTB-mediated viral production likely occurs through Ag-specific activation and infection of responding T cells.
New England Journal of MedicineThe Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter
485 Citations1996David Katzenstein, Scott M. Hammer +10 more
Both the risk of the progression of HIV disease and the efficacy of antiretroviral therapy are strongly associated with the plasma level of HIV RNA and with the viral phenotype.
JAMASafety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
430 Citations1988Margaret A. Fischl
Development of P carinii pneumonia was associated with the stage of Kaposi's sarcoma, B subtype disease, and the presence of 0.20 × 109/L (200/mm 3 ) or fewer CD4 cells at study entry.
New England Journal of MedicineClinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis
412 Citations1993Donald R. Hoover, Alfred J. Saah +5 more
Prophylaxis may delay the first AIDS illness for 6 to 12 months, and avium complex disease, esophageal candidiasis, wasting syndrome, and cytomegalovirus disease are more common in HIV-infected patients who have received prophylactic regimens against P. carinii than in those who have not.
New England Journal of MedicineEffect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1
376 Citations1996Sharilyn K. Stanley, Mario Ostrowski +8 more
Activation of the immune system by an ongoing antigen-specific immune response to an exogenous stimulus transiently increases the expression of HIV-1 and may enhance the susceptibility of uninfected subjects to HIV- 1.
New England Journal of MedicineA Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
322 Citations1995William G. Powderly, Dianne M. Finkelstein +12 more
A prospective, randomized trial that compared fluconazole with clotrimazole troches in patients who were also participating in a randomized trial of primary prophylaxis for Pneumocystis carinii pneumonia and found that the former was effective for long-term suppression of many fungal infections.
New England Journal of MedicineRace, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease
299 Citations1995Richard E. Chaisson, Jeanne Keruly +1 more
In the entire cohort, a lower CD4 cell count, a diagnosis of AIDS, older age, and the receipt of antiretroviral therapy before enrollment were associated with an increased risk of death, whereas the use of prophylaxis against pneumocystis pneumonia, zidovudine use after enrollment, and having a job at base line wereassociated with lower risks of death.
New England Journal of MedicineA Randomized Trial of Clarithromycin as Prophylaxis against Disseminated<i>Mycobacterium avium</i>Complex Infection in Patients with Advanced Acquired Immunodeficiency Syndrome
295 Citations1996Mark A. Pierce, Sheri L. Crampton +11 more
In patients with advanced AIDS, the prophylactic administration of clarithromycin is well tolerated, prevents M. avium complex infection, and reduces mortality.
Annals of Internal MedicineNatural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort
285 Citations1996Richard D. Moore, Richard E. Chaisson
The contemporary natural history of opportunistic disease in an urban population may be particularly relevant given the recent trends toward higher rates of HIV infection and the acquired immunodeficiency syndrome (AIDS) in women, members of racial and ethnic minority groups, and injection drug users.
American Review of Respiratory DiseaseIncidence and Natural History of <i>Mycobacterium avium</i> -Complex Infections in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine
165 Citations1992Richard E. Chaisson, Richard D. Moore +4 more
A proportional hazards analysis of survival showed that M. avium-complex infection, severe anemia, zidovudine dose interruption, occurrence of an opportunistic infection, CD4 cell count < 0.100 x 10(9)/L, baseline AIDS diagnosis, and transfusion independently predicted an increased risk of death.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyThe Effect of Thalidomide on the Pathogenesis of Human Immunodeficiency Virus Type 1 and M. tuberculosis Infection
157 Citations1996Jeffrey D. Klausner, Sanit Makonkawkeyoon +8 more
The results of this pilot study suggest that thalidomide may have a clinical role in enhancing weight gain and possibly reducing TNF-alpha and HIV- 1 levels in patients with HIV-1 and concomitant mycobacterial infections.
The LancetEffect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS
156 Citations1991Neil M.H. Graham, Scott L. Zeger +6 more
It is suggested that early primary PCP prophylaxis is effective in preventing first episodes of PCP, and that the efficacy of zidovudine demonstrated in clinical trials can be translated to the population level.
The Journal of Infectious DiseasesThe Effect of Influenza Vaccination on Human Immunodeficiency Virus Type 1 Load: A Randomized, Double-Blind, Placebo-Controlled Study
124 Citations1996Marshall J. Glesby, Donald R. Hoover +3 more
Influenza vaccination did not increase HIV-1 load in this controlled clinical trial and CD4 cell counts declined similarly in both groups at 6 months.
PubMedFactors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS).
123 Citations1994Alfred J. Saah, Donald R. Hoover +3 more
Young age, higher counts of CD4+ lymphocytes, hemoglobin, and absence of thrush or fever prior to AIDS onset were associated with longer survival after AIDS, as was prophylaxis for Pneumocystis carinii pneumonia (PCP).
The Journal of Infectious DiseasesThe Impact Of Mycobacterium AviumComplex Bacteremia And Its Treatment On Survival Of Aids Patients-A Prospective Study
122 Citations1994D P Chin, Arthur Reingold +8 more
This study prospectively followed a cohort of 367 AIDS patients with < or = 50 CD4+ cells/microL and found that MAC bacteremia was independently associated with an increased risk of death and treatment increases survival.
The Journal of Infectious DiseasesChanges in Virus Load Markers during AIDS-Associated Opportunistic Diseases in Human Immunodeficiency Virus-Infected Persons
120 Citations1996Richard Donovan, Charlene E. Bush +3 more
Clinical interpretation of plasma HIV RNA changes must take into account this reversible elevation during AIDS-associated opportunistic disease, as well as the recovery from disease.
Annals of Internal MedicineTrends in Infectious Diseases and Cancers among Persons Dying of HIV Infection in the United States from 1987 to 1992
113 Citations1995Richard M. Selik, Susan Y. Chu +1 more
The annual number of deaths associated with each disease generally increased as the total number of HIV-related deaths increased, but the relative rates of increase differed among diseases.
Annals of Internal MedicineProtease Inhibitors for HIV Infection
62 Citations1996John G. Bartlett
Squinavir is the first protease inhibitor to acquire FDA approval and is a potent inhibitor of HIV replication in vitro, but in vivo activity is modest at the recommended doses because of poor absorption and rapid hepatic metabolism.
Archives of Internal MedicinePneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine
59 Citations1992Richard E. Chaisson
Pneumocystis cariniipneumonia during follow-up was strongly associated with death when controlling for other factors, and consistent use of each was associated with improved survival.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyPatterns of Opportunistic Infections in Patients with HIV Infection
54 Citations1996Dianne M. Finkelstein, Paige L. Williams +6 more
The pattern of the development of opportunistic infections in HIV-infected patients was evaluated, based on a cohort of 1,530 patients enrolled in two AIDS Clinical Trials Group anti-retroviral studies, and it was found that the occurrence of each of these OIs increased the risk of subsequent OIs, even after adjusting for the CD4 count.
AIDSSurvival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS
47 Citations1995Richard D. Moore, Richard E. Chaisson
An analysis of the combined double- blind and open-label follow-up of two clinical trials of rifabutin prophylaxis for MAC supports the suggestion of the double-blind study that rifAButin improves survival of AIDS patients.
The Journal of Infectious DiseasesPrognostic Value of Viremia in Patients with Long-Standing Human Immunodeficiency Virus Infection
45 Citations1996Annick Galetto-Lacour, Sabine Yerly +5 more
Monitoring of HIV RNA level may help to identify patients who might benefit from antiretroviral or prophylactic therapy and to assess its use as a predictor of clinical progression and death.
Archives of Internal MedicinePneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group
20 Citations1992Richard E. Chaisson
Prophylaxis with trimethoprim-sulfamethoxazole and aerosol pentamidine both were associated with a decreased likelihood of PCP, and consistent use of each was associated with improved survival.